The USR is a flagship publication of UNESCO and is published once every five years, and is an oft-cited report on science, technology and innovation.

Functional and fair vaccine injury compensation programmes have the potential to boost confidence among the people.

The FDA's verdict is the second roadblock Bharat Biotech has faced with respect to rolling Covaxin out in other parts of the world.

By June 4, India had provided at least one dose to roughly 50 million people aged between 18 and 44, representing just 8% of that population group.

COVAX provided a good baseline model for expected public health needs, but the facility suffers from two major flaws.

Testing wastewater for the presence of SARS-CoV-2's nucleic acid is a widely recognised tool to identify areas where  case numbers are likely to  increase.